Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

PAVmed (PAVM) Gross Profit (2022 - 2025)

Historic Gross Profit for PAVmed (PAVM) over the last 4 years, with Q3 2025 value amounting to -$196000.0.

  • PAVmed's Gross Profit changed N/A to -$196000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$794000.0, marking a year-over-year change of. This contributed to the annual value of -$8.6 million for FY2024, which is 4295.16% up from last year.
  • According to the latest figures from Q3 2025, PAVmed's Gross Profit is -$196000.0.
  • Over the past 5 years, PAVmed's Gross Profit peaked at -$145000.0 during Q4 2024, and registered a low of -$5.6 million during Q4 2022.
  • Over the past 4 years, PAVmed's median Gross Profit value was -$3.3 million (recorded in 2024), while the average stood at -$2.5 million.
  • In the last 5 years, PAVmed's Gross Profit crashed by 217388.89% in 2023 and then skyrocketed by 9601.76% in 2024.
  • PAVmed's Gross Profit (Quarter) stood at -$5.6 million in 2022, then surged by 35.52% to -$3.6 million in 2023, then surged by 96.02% to -$145000.0 in 2024, then plummeted by 35.17% to -$196000.0 in 2025.
  • Its Gross Profit was -$196000.0 in Q3 2025, compared to -$214000.0 in Q2 2025 and -$239000.0 in Q1 2025.